Immuno-Biological Laboratories4570 
$3.170.22%24h
0.22%24h
Global rank28001
Market cap$29.54M
Change 7d-3.22%
YTD Performance-7.96%
SP500 benchmarkUnderperform
P/E-0.10
P/S5.29
Revenue$5.59M
Earnings-$2.04M
Dividend yield-
Main Sector
Healthcare
EPS for Immuno-Biological Laboratories (4570)
Immuno-Biological Laboratories has an EPS of $-31.1. In 2022, the company made an earnings per share (EPS) of $-27.78. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for 4570
-
Value:-
EPS history for Immuno-Biological Laboratories from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$31.10 | 11.95% |
| 2022 | -$27.78 | -18.84% |
| 2021 | -$34.23 | -54.96% |
| 2020 | -$76.00 | - |
View the highest EPS stocks
